HYDROXYPHENYL-ETHYNYL-PHENOL DERIVATIVES AS AR (ANDROGEN RECEPTOR) TRANSCRIPTIONAL ACTIVITY MODULATORS FOR USE IN THE TREATMENT OF I.A. PROSTATE CANCER

The present invention relates to compounds of formula (I) and their use for modulating the transcriptional activity of the androgen receptor and its splice variants for treating various indications including prostate cancer La présente invention concerne des composés de formule (I) et leur utilisati...

Full description

Saved in:
Bibliographic Details
Main Authors VERDAGUER ESPAULELLA, Francesc Xavier, SADAR, Marianne Dorothy, SÁNCHEZ ZARZALEJO, Carolina, RIERA ESCALÉ, Antoni, FRIGOLÉ VIVAS, Marta, SALVATELLA GIRALT, Xavier, RUFFONI, Alessandro, BANUELOS, Carmen Adriana, MAWJI, Nasrin
Format Patent
LanguageEnglish
French
Published 20.04.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds of formula (I) and their use for modulating the transcriptional activity of the androgen receptor and its splice variants for treating various indications including prostate cancer La présente invention concerne des composés de formule (I) et leur utilisation pour moduler l'activité transcriptionnelle du récepteur des androgènes et ses variants d'épissage pour traiter diverses indications, notamment le cancer de la prostate.
Bibliography:Application Number: WO2022EP76442